335 related articles for article (PubMed ID: 23806533)
1. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
[TBL] [Abstract][Full Text] [Related]
2. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
[TBL] [Abstract][Full Text] [Related]
3. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M
Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876
[TBL] [Abstract][Full Text] [Related]
4. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric
Leithner D; Helbich TH; Bernard-Davila B; Marino MA; Avendano D; Martinez DF; Jochelson MS; Kapetas P; Baltzer PAT; Haug A; Hacker M; Tanyildizi Y; Morris EA; Pinker K
J Nucl Med; 2020 Jan; 61(1):20-25. PubMed ID: 31253745
[TBL] [Abstract][Full Text] [Related]
7. Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.
Mema E; Mango VL; Guo X; Karcich J; Yeh R; Wynn RT; Zhao B; Ha RS
J Magn Reson Imaging; 2018 Mar; 47(3):753-759. PubMed ID: 28646614
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
[TBL] [Abstract][Full Text] [Related]
9. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
Kim E; Mema E; Axelrod D; Sigmund E; Kim SG; Babb J; Melsaether AN
Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
[TBL] [Abstract][Full Text] [Related]
10. The effect of age, menopausal state, and breast density on (18)F-FDG uptake in normal glandular breast tissue.
Mavi A; Cermik TF; Urhan M; Puskulcu H; Basu S; Cucchiara AJ; Yu JQ; Alavi A
J Nucl Med; 2010 Mar; 51(3):347-52. PubMed ID: 20150253
[TBL] [Abstract][Full Text] [Related]
11. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
MacDonald LR; Hippe DS; Bender LC; Cotter EW; Voria PR; Hallam PS; Wang CL; Haseley DR; Kelly MM; Parikh JR; Beatty JD; Rogers JV
J Nucl Med; 2016 Mar; 57(3):348-54. PubMed ID: 26635337
[TBL] [Abstract][Full Text] [Related]
12. Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound.
Ko ES; Lee BH; Choi HY; Kim RB; Noh WC
Eur J Radiol; 2011 Dec; 80(3):719-23. PubMed ID: 20709479
[TBL] [Abstract][Full Text] [Related]
13. Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?
Hansen NL; Kuhl CK; Barabasch A; Strobel K; Schrading S
J Magn Reson Imaging; 2014 Aug; 40(2):483-9. PubMed ID: 24446230
[TBL] [Abstract][Full Text] [Related]
14. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
[TBL] [Abstract][Full Text] [Related]
15. Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
Lee YJ; Choi BB; Suh KS
Acta Radiol; 2015 Jun; 56(6):644-51. PubMed ID: 24938660
[TBL] [Abstract][Full Text] [Related]
16. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
Yoon HJ; Kim Y; Lee JE; Kim BS
Eur Radiol; 2015 Jan; 25(1):32-40. PubMed ID: 25216768
[TBL] [Abstract][Full Text] [Related]
17. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
18. A multiparametric [
Leithner D; Horvat JV; Bernard-Davila B; Helbich TH; Ochoa-Albiztegui RE; Martinez DF; Zhang M; Thakur SB; Wengert GJ; Staudenherz A; Jochelson MS; Morris EA; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1878-1888. PubMed ID: 31197455
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of positron emission mammography: feature analysis and rates of malignancy.
Narayanan D; Madsen KS; Kalinyak JE; Berg WA
AJR Am J Roentgenol; 2011 Apr; 196(4):956-70. PubMed ID: 21427350
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
